Trial Profile
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Iloprost (Primary) ; Warfarin
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 19 Sep 2014 New trial record